Abstract
The question of vascular tolerance was examined in 154 patients with acute myocardial infarction (64 anterior, 90 inferior) who were treated with prolonged low dose intravenous nitroglycerin in a recent randomized placebo-controlled study. The dose of nitroglycerin was carefully titrated to decrease mean blood pressure by 10% in normotensive patients and 30% in hypertensive (blood pressure greater than 140/90 mm Hg) patients, but not less than 80 mm Hg. Tolerance was defined as the need to increase the dose to maintain this hemodynamic effect. It was labelled "true" if chest pain was absent and "apparent" if chest pain was present. Group analysis of dose, pain scores, hemodynamic, 2-dimensional echocardiographic and clinical parameters monitored serially before and after therapy indicated benefit with nitroglycerin over placebo despite equalizing of blood pressures after 10 hours. Reversal of blood pressures and volumes after discontinuing nitroglycerin suggested lack of significant tolerance. However, detailed individual analysis suggested significant hemodynamic tolerance in 37 patients (24%), both in the true tolerance (12%) and apparent tolerance (12%) subgroups. Tolerance appeared early, requiring the dose to be increased ...Continue Reading
References
Jan 1, 1975·Circulation·J T FlahertyB Pitt
Mar 1, 1986·Annals of Internal Medicine·R A JordanJ Franciosa
Sep 1, 1986·Circulation·D J StewartE Bassenge
Sep 1, 1987·Circulation·U ElkayamS H Rahimtoola
Sep 24, 1987·The New England Journal of Medicine·M PackerM Yushak
Jun 1, 1988·Circulation·D ZimrinH L Fung
Oct 1, 1988·Circulation·B I Jugdutt, J W Warnica
Jun 4, 1987·The New England Journal of Medicine·J O ParkerG Moe
Apr 1, 1983·Circulation·C V LeierD V Unverferth
May 1, 1983·British Heart Journal·A S JaffeR Roberts
Sep 1, 1983·Circulation·J T FlahertyM L Weisfeldt
Sep 1, 1983·Circulation·B I Jugdutt
Dec 1, 1983·Circulation·B I JugduttR E Rossall
Jan 1, 1984·Intensive Care Medicine·Y LisD Robson
Mar 1, 1980·The American Journal of Cardiology·J A Franciosa, J N Cohn
Jan 1, 1981·Circulation·B I JugduttC H Kallman
Mar 1, 1981·Circulation·W D BussmannM Kaltenbach
Sep 1, 1981·Circulation·M PackerR Gorlin
Citations
Aug 1, 1994·Cardiovascular Drugs and Therapy·B I Jugdutt
Jul 1, 1995·Journal of the American College of Cardiology·M JeserichH Just
May 30, 1996·The American Journal of Cardiology·B I Jugdutt
Aug 20, 1994·Lancet·M Sardina, J Mizrahi
Oct 1, 1996·Current Problems in Cardiology·P A Ribeiro, P M Shah
Dec 10, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M V MonzaniM Sardina
Jan 1, 1992·Acta Anaesthesiologica Scandinavica. Supplementum·G Ohqvist
Jan 1, 1995·Gut·A L JonesP C Hayes
Feb 3, 2004·The Journal of Clinical Investigation·Karsten SydowThomas Münzel
Dec 15, 2010·Clinical Interventions in Aging·Bodh I Jugdutt
Feb 27, 2007·Vascular Health and Risk Management·Bodh I Jugdutt
Nov 18, 1991·The American Journal of Cardiology·B I Jugdutt
Sep 24, 1992·The American Journal of Cardiology·J D Horowitz
Sep 24, 1992·The American Journal of Cardiology·B I Jugdutt
Nov 27, 1992·The American Journal of Cardiology·E A Amsterdam
Dec 16, 1993·The American Journal of Cardiology·B I Jugdutt
Jan 25, 1991·The American Journal of Cardiology·R C Becker, J M Gore
Feb 24, 2001·Alimentary Pharmacology & Therapeutics·D Tripathi, P C Hayes
Mar 13, 2002·Circulation·Eberhard SchulzThomas Münzel
Apr 1, 1995·Hypertension·K A KaasjagerT J Rabelink
May 23, 2001·Circulation·A MülschT Münzel
Jan 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T IwaoK Tanikawa
Aug 13, 1998·Journal of Cardiovascular Pharmacology·R S KhattarA Lahiri
Apr 6, 2017·Frontiers in Pharmacology·Chen Huei LeoLaura J Parry
Jan 1, 1994·Heart and Vessels·B I Jugdutt